Register to leave comments

  • News bot May 7, 2026, 8:16 p.m.

    🔍 MATA NATHAN L. (Executive)

    Company: BELITE BIO, INC (BLTE)

    Report Date: 2026-05-06

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,000

    Detailed Transactions and Holdings:

    • Sold 8 shares of American depositary share at $151.57 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 1,658.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 424 shares of American depositary share at $152.6717 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 1,234.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
    • Sold 128 shares of American depositary share at $153.4183 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 1,106.00 | transaction_form_type: 4 | Footnotes: F1, F2, F5
    • Sold 240 shares of American depositary share at $154.4117 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 866.00 | transaction_form_type: 4 | Footnotes: F1, F2, F6
    • Sold 100 shares of American depositary share at $155.97 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 766.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 100 shares of American depositary share at $156.0 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: false | shares_owned_after: 666.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
    • F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.
    • F3: Represents the weighted average price of shares sold at prices that ranged from $151.17 to $151.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
    • F4: Represents the weighted average price of shares sold at prices that ranged from $152.25 to $152.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
    • F5: Represents the weighted average price of shares sold at prices that ranged from $153 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
    • F6: Represents the weighted average price of shares sold at prices that ranged from $154.02 to $154.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.